Dr. Mooney introduces himself, explaining why he got involved with EchoTherapeutics, and gives an explains the Symphony and where they are testing it first.
More videos with Dr. Mooney:
Patrick Mooney, MD, is the chairman and CEO of Echo Therapeutics and a surgeon by training. He did his surgical residency at Thomas Jefferson University Hospital in Philadelphia after which he left medicine and began working on Wall Street as a securities analyst covering biotechnology companies. He later left Wall Street to run another biotechnology company, and then joined Echo Therapeutics in 2007.
Echo uses a technology that came out of Dr. Robert Langer’s lab at MIT. Dr. Langer invented a device which permeates the skin without needing a needle to penetrate the protective barrier formed by the skin. The device creates a portal into the body to deliver drugs topically or extract analytes, and Echo used this system to create a glucose biosensor, the Symphony tCGM System, to read continuously without the use of a needle.